Selected research
Industry Research
Prothrombin Complex Industry Research Report 2026
Market perspective
The global Prothrombin Complex market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prothrombin Complex is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prothrombin Complex is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prothrombin Complex include Takeda, Hualan Biological, Octapharma, Meheco Xinxing Pharma, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prothrombin Complex market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prothrombin Complex Market by Company
Takeda
Hualan Biological
Octapharma
Meheco Xinxing Pharma
Grifols
CSL
Prothrombin Complex Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Prothrombin Complex Segment by Application
Hemophilia B
Vitamin K Deficiency
Others
Prothrombin Complex Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prothrombin Complex manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prothrombin Complex by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prothrombin Complex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Applications
- Hemophilia B
- Vitamin K Deficiency
- Others
Companies covered
- Takeda
- Hualan Biological
- Octapharma
- Meheco Xinxing Pharma
- Grifols
- CSL
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prothrombin Complex Market Size (2021-2032)
- 2.2.2 Global Prothrombin Complex Sales (2021-2032)
- 2.2.3 Global Prothrombin Complex Market Average Price (2021-2032)
- 2.3 Prothrombin Complex by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 500 IU/Vial
- 2.3.3 600 IU/Vial
- 2.3.4 1000 IU/Vial
- 2.3.5 Others
- 2.4 Prothrombin Complex by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hemophilia B
- 2.4.3 Vitamin K Deficiency
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prothrombin Complex Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prothrombin Complex Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Prothrombin Complex Revenue of Manufacturers (2021-2026)
- 3.4 Global Prothrombin Complex Average Price by Manufacturers (2021-2026)
- 3.5 Global Prothrombin Complex Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prothrombin Complex, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prothrombin Complex, Product Type & Application
- 3.8 Global Manufacturers of Prothrombin Complex, Established Date
- 3.9 Global Prothrombin Complex Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Prothrombin Complex Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 Hualan Biological
- 4.2.1 Hualan Biological Company Information
- 4.2.2 Hualan Biological Business Overview
- 4.2.3 Hualan Biological Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hualan Biological Prothrombin Complex Product Portfolio
- 4.2.5 Hualan Biological Recent Developments
- 4.3 Octapharma
- 4.3.1 Octapharma Company Information
- 4.3.2 Octapharma Business Overview
- 4.3.3 Octapharma Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Octapharma Prothrombin Complex Product Portfolio
- 4.3.5 Octapharma Recent Developments
- 4.4 Meheco Xinxing Pharma
- 4.4.1 Meheco Xinxing Pharma Company Information
- 4.4.2 Meheco Xinxing Pharma Business Overview
- 4.4.3 Meheco Xinxing Pharma Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Meheco Xinxing Pharma Prothrombin Complex Product Portfolio
- 4.4.5 Meheco Xinxing Pharma Recent Developments
- 4.5 Grifols
- 4.5.1 Grifols Company Information
- 4.5.2 Grifols Business Overview
- 4.5.3 Grifols Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Grifols Prothrombin Complex Product Portfolio
- 4.5.5 Grifols Recent Developments
- 4.6 CSL
- 4.6.1 CSL Company Information
- 4.6.2 CSL Business Overview
- 4.6.3 CSL Prothrombin Complex Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CSL Prothrombin Complex Product Portfolio
- 4.6.5 CSL Recent Developments
5 Global Prothrombin Complex Market Scenario by Region
- 5.1 Global Prothrombin Complex Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prothrombin Complex Sales by Region: 2021-2032
- 5.2.1 Global Prothrombin Complex Sales by Region: 2021-2026
- 5.2.2 Global Prothrombin Complex Sales by Region: 2027-2032
- 5.3 Global Prothrombin Complex Revenue by Region: 2021-2032
- 5.3.1 Global Prothrombin Complex Revenue by Region: 2021-2026
- 5.3.2 Global Prothrombin Complex Revenue by Region: 2027-2032
- 5.4 North America Prothrombin Complex Market Facts & Figures by Country
- 5.4.1 North America Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prothrombin Complex Sales by Country (2021-2032)
- 5.4.3 North America Prothrombin Complex Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Prothrombin Complex Market Facts & Figures by Country
- 5.5.1 Europe Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prothrombin Complex Sales by Country (2021-2032)
- 5.5.3 Europe Prothrombin Complex Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Prothrombin Complex Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prothrombin Complex Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prothrombin Complex Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prothrombin Complex Market Facts & Figures by Country
- 5.7.1 South America Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prothrombin Complex Sales by Country (2021-2032)
- 5.7.3 South America Prothrombin Complex Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Prothrombin Complex Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prothrombin Complex Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prothrombin Complex Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prothrombin Complex Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Prothrombin Complex Sales by Type (2021-2032)
- 6.1.1 Global Prothrombin Complex Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Prothrombin Complex Sales Market Share by Type (2021-2032)
- 6.2 Global Prothrombin Complex Revenue by Type (2021-2032)
- 6.2.1 Global Prothrombin Complex Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prothrombin Complex Revenue Market Share by Type (2021-2032)
- 6.3 Global Prothrombin Complex Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prothrombin Complex Sales by Application (2021-2032)
- 7.1.1 Global Prothrombin Complex Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Prothrombin Complex Sales Market Share by Application (2021-2032)
- 7.2 Global Prothrombin Complex Revenue by Application (2021-2032)
- 7.2.1 Global Prothrombin Complex Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prothrombin Complex Revenue Market Share by Application (2021-2032)
- 7.3 Global Prothrombin Complex Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prothrombin Complex Value Chain Analysis
- 8.1.1 Prothrombin Complex Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prothrombin Complex Production Mode & Process
- 8.2 Prothrombin Complex Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prothrombin Complex Distributors
- 8.2.3 Prothrombin Complex Customers
9 Global Prothrombin Complex Analyzing Market Dynamics
- 9.1 Prothrombin Complex Industry Trends
- 9.2 Prothrombin Complex Industry Drivers
- 9.3 Prothrombin Complex Industry Opportunities and Challenges
- 9.4 Prothrombin Complex Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst